You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 20, November 26, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Controversies
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Routine Antimicrobial Treatment of Acute Otitis Media

Is it Necessary?

Larry Culpepper, MD, MPH; Jack Froom, MD

JAMA. 1997;278(20):1643-1645.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EVIDENCE THAT routine antimicrobial treatment improves the course and outcomes after acute otitis media is weak. Given the lack of evidence for benefit and the potential for adverse effects, including altering normal respiratory flora and development of resistant organisms, routine treatment using 10 days of antimicrobials for all cases of acute otitis media is not warranted.

See also p 1640.

There have been 7 randomized, blinded, placebo-controlled trials of acute otitis media over the past 30 years. Neither short- nor long-term differences were demonstrated in 3,1-3 and minor differences noted in the other 4 studies were limited to short-term benefits of antimicrobials.4-7 In a study by Howie and Ploussard,4 all case patients receiving placebo were asymptomatic at early follow-up (2 to 7 days) but had more positive tympanocentesis cultures than those receiving antimicrobials. Mygind et al5 found decreased pain in the penicillin group compared with the . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Family Medicine, Boston University School of Medicine, Boston, Mass (Dr Culpepper); and the Department of Family Medicine, School of Medicine, State University of New York at Stony Brook (Dr Froom).


Footnotes

Reprints: Larry Culpepper, MD, MPH, Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Boston, MA 02118.

Controversies section editor: Phil B. Fontanarosa, MD, Senior Editor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Controversies: Treatment of Acute Otitis Media
Michael J. Harkness, Asa Melhus, Ann Hermansson, Richard M. Rosenfeld, Jack L. Paradise, Jack Froom, Larry Culpepper, and Jack L. Paradise
JAMA. 1998;279(22):1783-1785.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.